Name | Title | Contact Details |
---|
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
SH3 is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ventiv Health is a Somerset, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
YMCA of Greater Brandywine is an association of eight YMCAs that offer life-changing programs for children, families and adults throughout Chester County, Pennsylvania.
Marimed Foundation is a Kaneohe, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.